Bavarian Nordic A/S (BAVA.CO)
BAVA.CO on Copenhagen Stock Exchange
170.60DKK
19 Sep 2018
170.60DKK
19 Sep 2018
Change (% chg)
kr.2.60 (+1.55%)
kr.2.60 (+1.55%)
Prev Close
kr.168.00
kr.168.00
Open
kr.170.85
kr.170.85
Day's High
kr.170.90
kr.170.90
Day's Low
kr.169.45
kr.169.45
Volume
22,321
22,321
Avg. Vol
230,309
230,309
52-wk High
kr.294.00
kr.294.00
52-wk Low
kr.158.55
kr.158.55
About
Bavarian Nordic A/S is a Denmark-based biotechnology company engaged in the development, production and marketing of vaccines for the treatment of cancer and infectious diseases. The Company’s drug pipeline comprises two areas: Cancer Immunotherapy and Infectious Disease. The Cancer Immunotherapy pipeline is focused on: prostate... (more)
Overall
| Beta: | 1.27 |
| Market Cap(Mil.): | kr.9,290.57 |
| Shares Outstanding(Mil.): | 31.98 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| BAVA.CO | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 40.08 | 30.93 | 32.76 |
| EPS (TTM): | 7.25 | -- | -- |
| ROI: | 11.17 | 15.07 | 14.61 |
| ROE: | 11.48 | 16.59 | 16.33 |
Estimates